Overlapping but Distinct Profiles of Gene Expression Elicited by Glucocorticoids and Progestins

Recent Progress in Hormone Research

Volumn 58, Issue , 2003, Pages 199-226

  Wan, Yihong ^a   Nordeen, Steven K ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; DEXAMETHASONE; GESTAGEN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; PROGESTERONE RECEPTOR; HORMONE; INTEGRASE; VIRUS PROTEIN;

DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; MOLECULAR RECOGNITION; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; UNINDEXED SEQUENCE; ANIMAL; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; PROMOTER REGION; RETROVIRUS;

ANIMALS; BLOTTING, NORTHERN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HORMONES; HUMANS; INTEGRASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGESTINS; PROMOTER REGIONS (GENETICS); RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL PROTEINS;

EID: 0042308467     PISSN: 00799963     EISSN: None     Source Type: Journal    
DOI: 10.1210/rp.58.1.199     Document Type: Review

References (70)

1. Abe H, Engler D, Molitch ME, Bollinger-Gruber J, Reichlin S 1985 Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat. Endocrinology 116:1383-1390
2. Allen JD, Verhoeven E, Domen J, van der Valk M, Berns A 1997 Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene 15:1133-1141
3. Bartsch J, Truss M, Bode J, Beato M 1996 Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure. Proc Natl Acad Sci USA 93:10741-10746
4. Baytel D, Shalom S, Madgar I, Weissenberg R, Don J 1998 The human Pim-2 proto-oncogene and its testicular expression. Biochim Biophys Acta 1442:274-285
5. Cato AC, Miksicek R, Schutz G, Arnemann J, Beato M 1986 The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. EMBO J 5:2237-2240
6. Chang W, Hubbard SC, Friedel C, Ruley HE 1993 Enrichment of insertional mutants following retrovirus gene trap selection. Virology 193:737-747
7. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY, Waxman S, Zelent A 1993 Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 12:1161-1167
8. David G, Alland L, Hong SH, Wong CW, DePinho RA, Dejean A 1998 Historic deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16:2549-2556
9. Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong HJ, Wang ZY, Licht J, Waxman S, Chomienne C, Chen Z, Zelent A, Chen SJ 1996 Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Proc Natl Acad Sci USA 93:3624-3629
10. Doppler W, Groner B, Ball RK 1989 Prolactin and glucocorticoid hormones synergistically induce expression of transfected rat beta-casein gene promoter constructs in a mammary epithelial cell line. Proc Natl Acad Sci USA 86:104-108
11. Fambrough D, McClure K, Kazlauskas A, Lander ES 1999 Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell 97:727-741
12. Fanjul AN, Bouterfa H, Dawson M, Pfahl M 1996 Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons. Cancer Res 56:1571-1577
13. Feng ZM, Bardin CW, Chen CL 1989 Characterization and regulation of testicular inhibin beta-subunit mRNA. Mol Endocrinol 3:939-948
14. Fu SL, Waha A, Vogt PK 2000 Identification and characterization of genes upregulated in cells transformed by v-Jun. Oncogene 19:3537-3545
15. Fusco O, Querzoli P, Nenci I, Natoli C, Brakebush C, Ullrich A, Iacobelli S 1998 90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells. Int J Cancer 79:23-26
16. Goya L, Maiyar AC, Ge Y, Firestone GL 1993 Glucocorticoids induce a G1/ G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha. Mol Endocrinol 7:1121-1132
17. Graham JD, Clarke CL 1997 Physiological action of progesterone in target tissues. Endocr Rev 18:502-519
18. Groner B, Altiok S, Meier V 1994 Hormonal regulation of transcription factor activity in mammary epithelial cells. Mol Cell Endocrinol 100:109-114
19. Groner B, Gouilleux F 1995 Prolactin-mediated gene activation in mammary epithelial cells. Curr Opin Genet Dev 5:587-594
20. Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA, Horwitz KB 1997 Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 11:1593-1607
21. Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA 1999 Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97:575-586
22. Heximer SP, Watson N, Linder ME, Blumer KJ, Hepler JR 1997 RGS2/G0S8 is a selective inhibitor of Gqalpha function. Proc Natl Acad Sci USA 94:14389-14393
23. Horwitz KB 1992 The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr Rev 13:146-163
24. Hynes N, van Ooyen AJ, Kennedy N, Herrlich P, Ponta H, Groner B 1983 Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene. Proc Natl Acad Sci USA 80:3637-3641
25. Jelinsky SA, Samson LD 1999 Global response of Saccharomyces cerevisiae to an alkylating agent. Proc Natl Acad Sci USA 96:1486-1491
26. Kondratyev AD, Chung KN, Jung MO 1996 Identification and characterization of a radiation-inducible glycosylated human early-response gene. Cancer Res 56:1498-1502
27. Korbelik M, Naraparaju VR, Yamamoto N 1998 The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy. Br J Cancer 77:1009-1014
28. Lambert JR, Nordeen SK 1998 Steroid-selective initiation of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter is controlled by the site of promoter integration. J Biol Chem 273:32708-32714
29. Lane NE, Lukert B 1998 The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin N Am 27:465-483
30. Lange CA, Richer JK, Horwitz KB 1999 Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 13:829-836
31. Lieberman BA, Bona BJ, Edwards DP, Nordeen SK 1993 The constitution of a progesterone response element. Mol Endocrinol 7:515-527
32. Lippman M, Bolan G, Huff K 1976 The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4602-4609
33. McKay LI, Cidlowski JA 1999 Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 20: 435-459
34. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
35. Miller AD, Buttimore C 1986 Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895-2902
36. Musgrove EA, Lee CS, Sutherland RL 1991 Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes. Mol Cell Biol 11:5032-5043
37. Nakamura H, Masutani H, Tagaya Y, Yamauchi A, Inamoto T, Nanbu Y, Fujii S, Ozawa K, Yodoi J 1992 Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma. Cancer 69:2091-2097
38. Nakamura H, Nakamura K, Yodoi J 1997 Redox regulation of cellular activation. Annu Rev Immunol 15:351-369
39. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, Yodoi J 1999 Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274:21645-21650
40. Nishizuka M, Honda K, Tsuchiya T, Nishihara T, Imagawa M 2001 RGS2 promotes adipocyte differentiation in the presence of ligand for peroxisome proliferator-activated receptor gamma. J Biol Chem 276:29625-29627
41. Nomura S, Hashmi S, McVey JH, Ham J, Parker M, Hogan BL 1989 Evidence for positive and negative regulatory elements in the 5′-flanking sequence of the mouse sparc (osteonectin) gene. J Biol Chem 264:12201-12207
42. Nordeen SK, Kuhnel B, Lawler-Heavner J, Barber DA, Edwards DP 1989 A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line. Mol Endocrinol 3:1270-1278
43. Oliveira-Dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ, Mariathasan S, Sasaki T, Wakeham A, Ohashi PS, Roder JC, Barnes CA, Siderovski DP, Penninger JM 2000 Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci USA 97:12272-12277
44. Payvar F, DeFranco D, Firestone GL, Edgar B, Wrange O, Okret S, Gustafsson JA, Yamamoto KR 1983 Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 35:381-392
45. Pietzsch A, Buchler C, Aslanidis C, Schmitz G 1997 Identification and characterization of a novel monocyte/macrophage differentiation-dependent gene that is responsive to lipopolysaccharide, ceramide, and lysophosphatidylcholine. Biochem Biophys Res Commun 235:4-9
46. Porterfield SP 1996 Endocrine Physiology. St. Louis: Mosby-Year Book: 139-146
47. Pratt WB, Toft DO 1997 Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18:306-360
48. Prior JC 1990 Progesterone as a bone-trophic hormone. Endocr Rev 11:386-398
49. Rackoff PJ, Rosen CJ 1998 Pathogenesis and treatment of glucocorticoid-induced osteoporosis. Drugs Aging 12:477-484
50. Raffo P, Emionite L, Colucci L, Belmondo F, Moro MG, Bollag W, Toma S 2000 Retinoid receptors: pathways of proliferation inhibition and apoptosis induction in breast cancer cell lines. Anticancer Res 20:1535-1543
51. Reddy S, DeGregori JV, von Melchner H, Ruley HE 1991 Retrovirus promoter-trap vector to induce lacZ gene fusions in mammalian cells. J Virol 65:1507-1515
52. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB 2002 Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277:5209-5218
53. Robinson GW, Hennighausen L 1997 Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 124:2701-2708
54. Russ AP, Friedel C, Ballas K, Kalina U, Zahn D, Strebhardt K, von Melchner H 1996 Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using gene-trap mutagenesis and site-specific recombination. Proc Natl Acad Sci USA 93:15279-15284
55. Schafer H, Lettau P, Trauzold A, Banasch M, Schmidt WE 1999 Human PACAP response gene 1 (p22/PRG1): proliferation-associated expression in pancreatic carcinoma cells. Pancreas 18:378-384
56. Scheidereit C, Geisse S, Westphal HM, Beato M 1983 The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature 304:749-752
57. Shaknovich R, Yeyati PL, Ivins S, Melnick A, Lempert C, Waxman S, Zelent A, Licht JD 1998 The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol Cell Biol 18:5533-5545
58. Siderovski DP, Heximer SP, Forsdyke DR 1994 A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells. DNA Cell Biol 13:125-147
59. Thackray VG, Lieberman BA, Nordeen SK 1998 Differential gene induction by glucocorticoid and progesterone receptors. J Steroid Biochem Mol Biol 66:171-178
60. Thornton JW 2001 Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proc Natl Acad Sci USA 98:5671-5676
61. von Melchner H, Reddy S, Ruley HE 1990 Isolation of cellular promoters by using a retrovirus promoter trap. Proc Natl Acad Sci USA 87:3733-3737
62. von Melchner H, Ruley HE 1989 Identification of cellular promoters by using a retrovirus promoter trap. J Virol 63:3227-3233
63. Wan Y, Nordeen SK 2002a Identification of genes differentially regulated by glucocorticoids and progestins using a Cre/loxP mediated retroviral promoter-trapping strategy. J Mol Endocrinol 28:177-192
64. Wan Y, Nordeen SK 2002b Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cells. Mol Endocrinol 16:1204-1214
65. Westin S, Rosenfeld MG, Glass CK 2000 Nuclear receptor coactivators. Adv Pharmacol 47:89-112
66. Yamamoto N, Naraparaju VR, Asbell SO 1996 Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients. Cancer Res 56:2827-2831
67. Yang X, Young LH, Voigt JM 1998 Expression of a vitamin D-regulated gene (VDUP-1) in untreated- and MNU-treated rat mammary tissue. Breast Cancer Res Treat 48:33-44
68. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, Nason-Burchenal K, Dmitrovsky E, Zelent A, Licht JD 1999 Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18:925-934
69. Yip-Schneider MT, Lin A, Marshall MS 2001 Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Biochem Biophys Res Commun 280:992-997
70. Ziegler R, Kasperk C 1998 Glucocorticoid-induced osteoporosis: prevention and treatment. Steroids 63:344-348